Discover
KRRO
Korro Bio, Inc.
13.65
2 x 9.73
2 x 16.56
bid
ask
+
0.47
3.57%
2 @ 04:00 PM
13.65 +0.00 (0.00%)
| Ytd | 70.41% | |
| 1y | 4.28% |
12.79
day range
13.78
5.20
52 week range
55.89
| Open | 13.11 | Prev Close | 13.18 | Low | 12.79 | High | 13.78 | Mkt Cap | 196.87M |
| Vol | 180.37K | Avg Vol | 175.23K | EPS | -11.68 | P/E | N/A | Forward P/E | -4.29 |
| Beta | N/A | Short Ratio | 2.64 | Inst. Own | 91.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 12.14 | 200-d Avg | 16.96 | 1yr Est | 137.76 |
| Income Statement | |||
| Operating Expenses | 20.44M | ||
| Research and Development Expense | 12.95M | ||
| Selling, General and Administrative Expense | 7.49M | ||
| Operating Income | -20.44M | ||
| Income Tax Expense | 95.00K | ||
| Net Income | -19.62M | ||
| Net Income Common Stock | -19.62M | ||
| Net Income Common Stock (USD) | -19.62M | ||
| Consolidated Income | -19.62M | ||
| Earnings per Basic Share | -1.69 | ||
| Earnings per Basic Share (USD) | -1.69 | ||
| Earnings per Diluted Share | -1.69 | ||
| Earning Before Interest & Taxes (EBIT) | -19.53M | ||
| Earning Before Interest & Taxes (USD) | -19.53M | ||
| Weighted Average Shares | 11.60M | ||
| Weighted Average Shares Diluted | 11.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 61.70M | ||
| Cash and Equivalents (USD) | 61.70M | ||
| Investments | 97.77M | ||
| Investments Current | 52.27M | ||
| Investments Non-Current | 45.49M | ||
| Current Assets | 120.16M | ||
| Property, Plant & Equipment Net | 15.62M | ||
| Total Assets | 183.62M | ||
| Debt Current | 2.80M | ||
| Total Debt | 42.89M | ||
| Current Liabilities | 14.79M | ||
| Debt Non-Current | 40.08M | ||
| Total Liabilities | 63.99M | ||
| Accumulated Retained Earnings (Deficit) | -403.47M | ||
| Accumulated Other Comprehensive Income | 5.00K | ||
| Shareholders Equity | 119.63M | ||
| Shareholders Equity (USD) | 119.63M | ||
| Assets Non-Current | 63.46M | ||
| Total Debt (USD) | 42.89M | ||
| Deferred Revenue | 7.84M | ||
| Liabilities Non-Current | 49.20M | ||
| Trade and Non-Trade Payables | 1.96M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 622.00K | ||
| Net Cash Flow from Financing | 88.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 39.87M | ||
| Capital Expenditure | -21.00K | ||
| Issuance (Purchase) of Equity Shares | 88.21M | ||
| Net Cash Flow from Investing | -32.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -32.22M | ||
| Net Cash Flow from Operations | -16.07M | ||
| Effect of Exchange Rate Changes on Cash | -25.00K | ||
| Share Based Compensation | 2.73M | ||